Efficacy and Safety of Dapagliflozin in Children With Proteinuric Chronic Kidney Disease

NCT04531397 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped lack of funding

Conditions

Proteinuria
Chronic Kidney Diseases

Interventions

DRUG: ACEI treatment
DRUG: Dapagliflozin+ACEI treatment

Sponsor

Children's Hospital of Fudan University